Recruiting and retaining older talent: 7 tips to make your business age-smart

If your business is struggling to find the right candidates for the right roles, perhaps it’s time to rethink what a ‘good’ candidate looks like. Perhaps it’s time to get ‘age-smart’.

Ubiquigent collaborates with University of Glasgow on translational structural biology to accelerate drug discovery within the (de)ubiquitylation field

Surgeons’ operations are race against time

Addenbrooke’s Hospital performs 20,000 planned operations a year – and at 9pm on Wednesday (25 Jan) BBC Two viewers will have the opportunity to see two of the most technically demanding.

Final days to enter Cambridge Independent Science and Technology Awards 2023

There are just days left to get your entry in to the Cambridge Independent Science and Technology Awards 2023. Enter free online by 11pm on January 27

New Year, new you, new offer from The Jockey Club

For every NEW conference booked and confirmed to take place from 5th January to 31st March 2023, you can take your pick from a variety of options to add to your Day Delegate package from Danish pastries to fresh fruit platters and add them to your event, completely free of charge! We can offer your delegates an abundance of space, access to outdoor areas and spacious private breakout lounges,…

Cresset January 2023 Newsletter

After a busy start to 2023, our January monthly update newsletter includes features around Flare Visualizer, Virtual Screening, Molecular Dynamics, and more!

First look at Cambridge Festival 2023

Hot topics this year include an in-depth look at how we move from global risks to global safety, results from the largest four-day working week trial, greenwashing tactics to look out for, the latest in AI (including a virtual game of football with AI players), and the future of heart valve replacement.

University of Exeter enters virtual screening collaboration with Cresset Discovery to accelerate discovery of novel antimicrobial drugs

Cresset Discovery, provider of molecular modeling expertise for drug discovery, is collaborating with the University of Exeter to find new antimicrobial drugs.

The FDA further expands collaboration with CN Bio to evaluate the PhysioMimix Multi-organ microphysiological system

CN Bio, a leading Organ-on-a-chip Company (OOC) that designs and manufactures single-and multi-organ microphysiological systems (MPS), today announced that the U.S.

TTP introduces Cellular Origins, a TTP Company focussed on delivering scalable manufacture of cell and gene therapies

TTP plc (TTP), a leading independent technology and product development company, has today announced the launch of Cellular Origins, a TTP Company. Cellular Origins is a TTP spin-out, created to enable s

Avacta Announces Successful Completion of Fourth Dose Escalation in AVA6000 Phase 1 Clinical Study

Avacta Group plc (AIM: AVCT), a life sciences company developing innovative, targeted oncology drugs and powerful diagnostics announces that AVA6000 continues to show a very favourable safety profile in the fourth dose cohort

Life-saving tech to treat babies closer to home

In a UK first, Cambridge University Hospitals has developed life-saving virtual technology that effectively “parachutes” its consultants into other hospitals, helping fellow medics across the region care for seriously ill babies.

CUH neurosurgeon wins prestigious Hunterian Professorship award

A consultant neurosurgeon from Addenbrooke’s Hospital has been given a prestigious award for his cutting-edge research into traumatic brain injury.

Tom’s Trust spread Christmas cheer to children in hospital

From superhero capes to books and cuddly soft toys, children were treated to some wonderful gifts from Tom’s Trust while spending time in hospital over the Christmas period.

The year in review: Updates and trends

In 2022, everyone witnessed intense activity in matters related to supply chain issues, the energy transition, oil & gas, post-M&A disputes, licensing issues, breaches of distribution contracts and increasingly arbitrations deriving from geopolitical issues in Europe and Asia and from com

Arecor announces transfer of AT307 to Hikma

License milestone to develop and commercialise ready-to-use medicine achieved. Arecor regains rights to AT282 following portfolio review at Hikma.

Surgery series shines spotlight on Addenbrooke’s

A television series that gives a unique insight into the world-class surgery undertaken at Addenbrooke’s Hospital launches next week.

Pheno Therapeutics announces worldwide license from UCB to a novel program for neurodegenerative disease

Preclinical program with potential for disease modifying therapeutic

Human respiratory pathogens will be tracked in new initiative

Wellcome Sanger Institute launches new initiative to better understand respiratory viruses.

o2h technology launches the tech kickstarter competition to support seed stage companies with their tech development needs

Cambridge, UK - o2h technology, a business vertical of the o2h group, is excited to announce the launch of the o2h tech kickstarter competition exclusively for seed stage life science, greentech, and tech/AI companies to help them boost their MVP, web, mobile app design & development activities.

FUJIFILM Irvine Scientific Launches HEK293 Feed, Specifically Designed for Viral Vector Production

Chemically defined, BalanCD HEK293 Viral Feed enhances viral vector production for gene therapy applications and viral vector-based vaccines

Local Employee Benefit Consultancy EBCam Ltd launches their 2023 survey to help companies benchmark their reward offering.

Specialist Employee Benefit consultancy EBcam Ltd, who are based out of Cambridge and Bury St Edmunds have re-launched their own employee benefit survey for 2023. The survey is free for local companies to participate in.

Vector BioPharma and iBET collaborate to develop high-throughput analytical methods and scalable processes for gene delivery

Vector BioPharma AG (Vector BioPharma), a biopharmaceutical company aiming to transform the safety, efficacy, and specificity of drug delivery to improve treatments for patients, today announced that it has entered into a strategic, multi-phase collaboration wi

AstraZeneca to acquire CinCor Pharma to strengthen cardiorenal pipeline

The acquisition will give access to global rights to baxdrostat, a novel aldosterone synthase inhibitor in development for blood pressure lowering.

2023: a new year with a renewed focus for the Guardtech Group

Cleanroom construction specialists’ multi-faceted approach set to reach new levels and new audiences in 2023.